Loading
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (2 ops.)
Latest filing published 12 Jan 2024 for Vera Therapeutics, Inc., €17.3M. Read the official filing
Filing timeline
BuySaleCommodore Capital LP
Insider track record
Disclosed buys
15
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-14.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Commodore Capital LP: trading record in brief
Filings by Commodore Capital LP span 4 companies, the busiest being Satsuma Pharmaceuticals, Inc., Enliven Therapeutics, Inc. and Vera Therapeutics, Inc. Over a trading history stretching from 15 October 2021 to 10 January 2024, the count stands at 17 filings.
Market trades split into 15 purchases (€7.9M) and 2 sales (€19.5M). No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2024 alone, the filings show no purchases and 1 sale.
A typical purchase (the median) is worth €46k. None of the 14 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 12 January 2024: an open-market sale of €17.3M, in Vera Therapeutics, Inc. The clock since the last published purchase (9 August 2023) now reads 1,166 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Commodore Capital LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
1,050,000 shares@ US$18.0073.5% of flowClass A Common StockSEC:0001493152-24-002290:0
775,756 shares@ €21.0421100.0% of flowCommon StockSEC:0001493152-23-027352:0
Canonical exit: 5 Nov 2023 (T+90)
448,217 shares@ US$15.16926.5% of flowClass A Common StockSEC:0001493152-23-022130:0
Canonical exit: 18 Sept 2023 (T+90)
621.75 shares@ US$22.072100.0% of flowCommon stock, par value $0.001 per shareSEC:0001493152-23-006118:0
Canonical exit: 24 May 2023 (T+90)
8,194 shares@ US$5.249100.0% of flowCommon stock, par value $0.001 per shareSEC:0001493152-23-005870:0
Canonical exit: 22 May 2023 (T+90)
3,250,000 shares@ US$0.70641.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-22-032622:0
2,922 shares@ US$5.420.4% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001545:0
Canonical exit: 22 Feb 2022 (T+90)
3,225 shares@ US$5.440.4% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001523:0
Canonical exit: 17 Feb 2022 (T+90)
9,622 shares@ US$5.851.3% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001471:0
Canonical exit: 8 Feb 2022 (T+90)
560 shares@ US$5.990.1% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001460:0
Canonical exit: 6 Feb 2022 (T+90)
1,400 shares@ US$5.880.2% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001450:0
Canonical exit: 2 Feb 2022 (T+90)
8,880 shares@ US$5.641.1% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001430:0
Canonical exit: 31 Jan 2022 (T+90)
44,651 shares@ US$5.715.7% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001420:0
Canonical exit: 27 Jan 2022 (T+90)
39,581 shares@ US$5.454.9% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001408:0
Canonical exit: 25 Jan 2022 (T+90)
32,816 shares@ US$5.404.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001391:0
Canonical exit: 19 Jan 2022 (T+90)
87,580 shares@ US$5.0710.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001384:0
Canonical exit: 17 Jan 2022 (T+90)
126,000 shares@ US$4.8313.8% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001373:0
Canonical exit: 13 Jan 2022 (T+90)
17 of 17 declarations
